Ftse Mib
34.825,01
0,00%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
71.148,60
-0,42%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Codiak BioSciences Inc (CDAK) Codiak BioSciences Inc (CDAK) Notizie

CDAK

Codiak BioSciences (CDAK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CDAK
DataOraFonteTitoloSimboloCompagnia
31/03/202300:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDAKCodiak BioSciences Inc
29/03/202312:05Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:CDAKCodiak BioSciences Inc
29/03/202312:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDAKCodiak BioSciences Inc
27/03/202313:00GlobeNewswire Inc.Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 ProcessNASDAQ:CDAKCodiak BioSciences Inc
03/03/202322:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDAKCodiak BioSciences Inc
14/02/202318:19Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CDAKCodiak BioSciences Inc
28/11/202219:00GlobeNewswire Inc.Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CDAKCodiak BioSciences Inc
10/11/202215:00GlobeNewswire Inc.Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual MeetingNASDAQ:CDAKCodiak BioSciences Inc
03/11/202221:01GlobeNewswire Inc.Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
12/10/202214:00GlobeNewswire Inc.Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related SarbecovirusesNASDAQ:CDAKCodiak BioSciences Inc
05/10/202214:00GlobeNewswire Inc.Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting MacrophagesNASDAQ:CDAKCodiak BioSciences Inc
20/09/202222:58Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CDAKCodiak BioSciences Inc
14/09/202212:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CDAKCodiak BioSciences Inc
13/09/202211:34TipRanksCodiak BioSciences (NASDAQ: CDAK) Drops Following Planned Public OfferingNASDAQ:CDAKCodiak BioSciences Inc
13/09/202203:05GlobeNewswire Inc.Codiak Announces Pricing of $20 Million Public Offering of Common Stock and WarrantsNASDAQ:CDAKCodiak BioSciences Inc
12/09/202222:01GlobeNewswire Inc.Codiak Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:CDAKCodiak BioSciences Inc
30/08/202215:10GlobeNewswire Inc.Codiak BioSciences Announces Program Reprioritization and Corporate RestructuringNASDAQ:CDAKCodiak BioSciences Inc
04/08/202222:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDAKCodiak BioSciences Inc
04/08/202222:01GlobeNewswire Inc.Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
03/08/202222:15GlobeNewswire Inc.Codiak BioSciences to Participate in Upcoming BTIG and Wedbush PacGrow Investor ConferencesNASDAQ:CDAKCodiak BioSciences Inc
11/07/202215:44GlobeNewswire Inc.Codiak BioSciences to Participate at William Blair Biotech Focus Conference 2022NASDAQ:CDAKCodiak BioSciences Inc
05/07/202214:33TipRanksGoldman Sachs Thinks Codiak BioSciences’ Stock is Going to RecoverNASDAQ:CDAKCodiak BioSciences Inc
05/07/202212:30GlobeNewswire Inc.CEPI and Codiak BioSciences partner to develop broadly protective Betacoronavirus vaccineNASDAQ:CDAKCodiak BioSciences Inc
02/07/202215:15TipRanksCodiak BioSciences (CDAK) Gets a Buy Rating from William BlairNASDAQ:CDAKCodiak BioSciences Inc
30/06/202212:30GlobeNewswire Inc.Codiak Provides Platform-Validating Clinical Update and Data from Phase 1 Trials of exoSTING™ and exoIL-12™NASDAQ:CDAKCodiak BioSciences Inc
29/06/202214:00GlobeNewswire Inc.Codiak Initiates Patient Dosing in Phase 1 Clinical Trial of exoASO™-STAT6 in Patients with Advanced Hepatocellular Carcinoma, Liver Metastases from Primary Gastric Cancer and Colorectal CancerNASDAQ:CDAKCodiak BioSciences Inc
17/05/202213:00GlobeNewswire Inc.Codiak Presents New Preclinical Data at ASGCT 2022 on Exosome-Based Strategy to Enhance AAV Gene TherapyNASDAQ:CDAKCodiak BioSciences Inc
05/05/202222:01GlobeNewswire Inc.Codiak BioSciences Reports First Quarter 2022 Financial Results and Operational ProgressNASDAQ:CDAKCodiak BioSciences Inc
04/05/202222:27Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDAKCodiak BioSciences Inc
02/05/202215:00GlobeNewswire Inc.Codiak Appoints David Mauro, M.D., Ph.D., as Chief Medical OfficerNASDAQ:CDAKCodiak BioSciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CDAK

La tua Cronologia

USOTC
LMLLF
Pharmadrug (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network